PKM and ovarian carcinoma: Specifically, RPN11/PSMD14 acts by reducing the ubiquitination on the K63 of PKM2 increasing the expression of the dimeric form and also favouring its nuclear translocation leading to aerobic glycolysis in tumors, including ovarian cancer 78.